Head and Neck Cancer Adaptive Radiation Therapy (ART): Conceptual Considerations for the Informed Clinician

Overview

Journal Semin Radiat Oncol

Specialties Oncology
Radiology

Date 2019 Apr 28

PMID 31027643

Citations 32

Authors

Jolien Heukelom

Clifton David Fuller

Affiliations

Soon will be listed here.

Abstract

For nearly 2 decades, adaptive radiation therapy (ART) has been proposed as a method to account for changes in head and neck tumor and normal tissue to enhance therapeutic ratios. While technical advances in imaging, planning and delivery have allowed greater capacity for ART delivery, and a series of dosimetric explorations have consistently shown capacity for improvement, there remains a paucity of clinical trials demonstrating the utility of ART. Furthermore, while ad hoc implementation of head and neck ART is reported, systematic full-scale head and neck ART remains an as yet unreached reality. To some degree, this lack of scalability may be related to not only the complexity of ART, but also variability in the nomenclature and descriptions of what is encompassed by ART. Consequently, we present an overview of the history, current status, and recommendations for the future of ART, with an eye toward improving the clarity and description of head and neck ART for interested clinicians, noting practical considerations for implementation of an ART program or clinical trial. Process level considerations for ART are noted, reminding the reader that, paraphrasing the writer Elbert Hubbard, "Art is not a thing, it is a way."

Citing Articles

Artificial intelligence across oncology specialties: current applications and emerging tools.

Kang J, Lafata K, Kim E, Yao C, Lin F, Rattay T BMJ Oncol. 2025; 3(1):e000134.

PMID: 39886165 PMC: 11203066. DOI: 10.1136/bmjonc-2023-000134.

A treatment-site-specific evaluation of commercial synthetic computed tomography solutions for proton therapy.

Yeap P, Wong Y, Lee K, Koh C, Lew K, Chua C Phys Imaging Radiat Oncol. 2024; 31:100639.

PMID: 39297079 PMC: 11407964. DOI: 10.1016/j.phro.2024.100639.

Technical Development and In Silico Implementation of SyntheticMR in Head and Neck Adaptive Radiation Therapy: A Prospective R-IDEAL Stage 0/1 Technology Development Report.

McCullum L, Mulder S, West N, Aghoghovbia R, Ali A, Scott H medRxiv. 2024; .

PMID: 39252894 PMC: 11383512. DOI: 10.1101/2024.08.29.24312591.

Radiation-induced skin injury in the head and neck region: pathogenesis, clinics, prevention, treatment considerations and proposal for management algorithm.

Pazdrowski J, Gornowicz-Porowska J, Kazmierska J, Krajka-Kuzniak V, Polanska A, Masternak M Rep Pract Oncol Radiother. 2024; 29(3):373-390.

PMID: 39144266 PMC: 11321788. DOI: 10.5603/rpor.100775.

Does adaptive radiotherapy for head and neck cancer favorably impact dosimetric, clinical, and toxicity outcomes?: A review.

Simopoulou F, Kyrgias G, Georgakopoulos I, Avgousti R, Armpilia C, Skarlos P Medicine (Baltimore). 2024; 103(26):e38529.

PMID: 38941415 PMC: 11466102. DOI: 10.1097/MD.0000000000038529.

References

Kashani R, Hub M, Balter J, Kessler M, Dong L, Zhang L . Objective assessment of deformable image registration in radiotherapy: a multi-institution study. Med Phys. 2009; 35(12):5944-53. PMC: 2673610. DOI: 10.1118/1.3013563. View

Olteanu L, Berwouts D, Madani I, De Gersem W, Vercauteren T, Duprez F . Comparative dosimetry of three-phase adaptive and non-adaptive dose-painting IMRT for head-and-neck cancer. Radiother Oncol. 2014; 111(3):348-53. DOI: 10.1016/j.radonc.2014.02.017. View

Hansch A, Schwier M, Gass T, Morgas T, Haas B, Dicken V . Evaluation of deep learning methods for parotid gland segmentation from CT images. J Med Imaging (Bellingham). 2018; 6(1):011005. PMC: 6165912. DOI: 10.1117/1.JMI.6.1.011005. View

Matuszak M, Fuller C, Yock T, Hess C, McNutt T, Jolly S . Performance/outcomes data and physician process challenges for practical big data efforts in radiation oncology. Med Phys. 2018; 45(10):e811-e819. PMC: 6679351. DOI: 10.1002/mp.13136. View

Gregoire V, Ang K, Budach W, Grau C, Hamoir M, Langendijk J . Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. Radiother Oncol. 2013; 110(1):172-81. DOI: 10.1016/j.radonc.2013.10.010. View

Barker Jr J, Garden A, Ang K, ODaniel J, Wang H, Court L . Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system. Int J Radiat Oncol Biol Phys. 2004; 59(4):960-70. DOI: 10.1016/j.ijrobp.2003.12.024. View

Papiez L, Langer M . On probabilistically defined margins in radiation therapy. Phys Med Biol. 2006; 51(16):3921-39. DOI: 10.1088/0031-9155/51/16/003. View

van Dijk L, Noordzij W, Brouwer C, Boellaard R, Burgerhof J, Langendijk J . F-FDG PET image biomarkers improve prediction of late radiation-induced xerostomia. Radiother Oncol. 2017; 126(1):89-95. DOI: 10.1016/j.radonc.2017.08.024. View

Rasmussen J, Hakansson K, Vogelius I, Aznar M, Fischer B, Friborg J . Phase I trial of 18F-Fludeoxyglucose based radiation dose painting with concomitant cisplatin in head and neck cancer. Radiother Oncol. 2016; 120(1):76-80. DOI: 10.1016/j.radonc.2016.03.005. View

10.

Cousijn H, Kenall A, Ganley E, Harrison M, Kernohan D, Lemberger T . A data citation roadmap for scientific publishers. Sci Data. 2018; 5:180259. PMC: 6244190. DOI: 10.1038/sdata.2018.259. View

11.

Fedorov A, Clunie D, Ulrich E, Bauer C, Wahle A, Brown B . DICOM for quantitative imaging biomarker development: a standards based approach to sharing clinical data and structured PET/CT analysis results in head and neck cancer research. PeerJ. 2016; 4:e2057. PMC: 4888317. DOI: 10.7717/peerj.2057. View

12.

Mahmoud O, Reis I, Samuels M, Elsayyad N, Bossart E, Both J . Prospective Pilot Study Comparing the Need for Adaptive Radiotherapy in Unresected Bulky Disease and in Postoperative Patients With Head and Neck Cancer. Technol Cancer Res Treat. 2017; 16(6):1014-1021. PMC: 5762062. DOI: 10.1177/1533034617717624. View

13.

Duma M, Kampfer S, Schuster T, Winkler C, Geinitz H . Adaptive radiotherapy for soft tissue changes during helical tomotherapy for head and neck cancer. Strahlenther Onkol. 2012; 188(3):243-7. DOI: 10.1007/s00066-011-0041-8. View

14.

Voet P, Dirkx M, Teguh D, Hoogeman M, Levendag P, Heijmen B . Does atlas-based autosegmentation of neck levels require subsequent manual contour editing to avoid risk of severe target underdosage? A dosimetric analysis. Radiother Oncol. 2011; 98(3):373-7. DOI: 10.1016/j.radonc.2010.11.017. View

15.

Law M, Liu B, Chan L . Informatics in radiology: DICOM-RT-based electronic patient record information system for radiation therapy. Radiographics. 2009; 29(4):961-72. DOI: 10.1148/rg.294085073. View

16.

Kalpathy-Cramer J, Freymann J, Kirby J, Kinahan P, Prior F . Quantitative Imaging Network: Data Sharing and Competitive AlgorithmValidation Leveraging The Cancer Imaging Archive. Transl Oncol. 2014; 7(1):147-52. PMC: 3998686. DOI: 10.1593/tlo.13862. View

17.

Zhang P, Simon A, Rigaud B, Castelli J, Ospina Arango J, Nassef M . Optimal adaptive IMRT strategy to spare the parotid glands in oropharyngeal cancer. Radiother Oncol. 2016; 120(1):41-7. DOI: 10.1016/j.radonc.2016.05.028. View

18.

Brodin N, Tome W . Revisiting the dose constraints for head and neck OARs in the current era of IMRT. Oral Oncol. 2018; 86:8-18. PMC: 6481934. DOI: 10.1016/j.oraloncology.2018.08.018. View

19.

Duprez F, De Neve W, De Gersem W, Coghe M, Madani I . Adaptive dose painting by numbers for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2010; 80(4):1045-55. DOI: 10.1016/j.ijrobp.2010.03.028. View

20.

Lee T, Fang F . Quantitative analysis of normal tissue effects in the clinic (QUANTEC) guideline validation using quality of life questionnaire datasets for parotid gland constraints to avoid causing xerostomia during head-and-neck radiotherapy. Radiother Oncol. 2013; 106(3):352-8. DOI: 10.1016/j.radonc.2012.11.013. View